Genetic mutations in genes encoding proteins involved in epigenetic machinery have been reported in individuals with autism spectrum disorder (ASD), intellectual disability, congenital heart disease, and other disorders. H1 histone linker protein, the basic component in nucleosome packaging and chromatin organization, has not been implicated in human disease until recently. We (19.5%) genes are directly involved in epigenetic regulations and the majority of these genes belong to histone writers, readers, and erasers. While the mechanism of how haploinsufficiency of HIST1H1E causes autism is entirely unknown, our report underscores the importance of further study of the function of this protein and other histone linker proteins in brain development.
Genetic mutations in genes encoding proteins involved in epigenetic machinery have been reported in individuals with autism spectrum disorder (ASD), intellectual disability, congenital heart disease, and other disorders. H1 histone linker protein, the basic component in nucleosome packaging and chromatin organization, has not been implicated in human disease until recently. We report a de novo deleterious mutation of histone cluster 1 H1 family member e (HIST1H1E; c.435dupC; p.Thr146Hisfs*50), encoding H1 histone linker protein H1.4, in a 10-year-old boy with autism and intellectual disability diagnosed through clinical whole exome sequencing. The c.435dupC at the 3 0 end of the mRNA leads to a frameshift and truncation of the positive charge in the carboxy-terminus of the protein. An expression study demonstrates the mutation leads to reduced protein expression, supporting haploinsufficiency of HIST1H1E protein and loss of function as an underlying mechanism of dysfunction in the brain. Taken together with other recent cases with mutations of HIST1H1E in intellectual disability, the evidence supporting the link to causality in disease is strong. Our finding implicates the deficiency of H1 linker histone protein in autism. The systematic review of candidate genes implicated in ASD revealed that 42 of 215 (19.5%) genes are directly involved in epigenetic regulations and the majority of these genes belong to histone writers, readers, and erasers. While the mechanism of how haploinsufficiency of HIST1H1E causes autism is entirely unknown, our report underscores the importance of further study of the function of this protein and other histone linker proteins in brain development.
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| I N TR ODU C TI ON
Eukaryotic DNA is packaged and maintained within highly regulated chromatin structures through association with various histone proteins.
The fundamental unit of chromatin, the nucleosome, consists of 146 bp units of DNA wrapped around an octamer of core histone proteins, H2A, H2B, H3, and H4 (Zlatanova, Leub, & van Holde, 1999) . H1 linker, the fifth histone protein, exists near the base of the nucleosome at DNA entry and exit sites, and is involved in the folding and stabilization of the 30 nm chromatin fiber (Brown, 2003; Bustin, Catez, & Lim, 2005) . The H1 histone family is the most divergent class of histones, with at least 11 different types present in humans. They have a tripartite structure consisting of a short N-terminus enriched in basic amino acids, a central conserved globular H15 domain important for DNA binding, and a long C-terminal tail enriched in lysine, serine, and proline.
H1 linker histone proteins are believed to contribute to the organization and stabilization of chromosomal DNA, in addition to the folding of nucleosome filaments into higher-order structures and modulation of gene transcription (Happel & Doenecke, 2009; Harshman et al., 2013; Harvey & Downs, 2004; Trollope, Sapojnikova, Thorne, CraneRobinson, & Myers, 2010; Xiao, Freedman, Miller, Heald, & Marko, 2012) . Mouse models knocking out expression of various linker histones, including specific H1 subtypes, confirm these proteins are involved in regulating specific genes and specific processes (Sancho, Diani, Beato, & Jordan, 2008) . Sequentially inactivating multiple H1 family genes in mutant mice demonstrates the total amount of H1 present is critical for proper embryonic development. Different H1 variants have different temporal-and spatial-expression profiles (Happel & Doenecke, 2009 ), suggesting a distinct role for individual histone linkers during development. However, this has not been investigated.
HIST1H1E (histone cluster 1 H1 family member e) is one of 11 H1
linker genes, and encodes histone H1.4 or H1E. It belongs to the subgroup of replication dependent histones mainly expressed in the S phase of the cell cycle, believed to be involved in heterochromatin formation through their interaction with HP1 (Vaquero et al., 2004) .
Depletion of H1.4 leads to arrest of cell proliferation (Sancho et al., 2008) . The C-terminus of H1.4 typically has an abundance of lysine residues, and is almost completely devoid of acidic and highly hydrophobic amino acids (Kasinsky, Lewis, Dacks, & Ausi o, 2001 ), resulting in 30-50 net positive charges (Subirana, 1990 ). This region is important for stable folding of nucleosome arrays in chromatin fibers (Allan, Mitchell, Harborne, Bohm, & Crane-Robinson, 1986) and is required for high-affinity binding to chromatin in vivo (Hendzel, Lever, Crawford, & Th'ng, 2004) .
Here, we report a de novo frameshift mutation in the HIST1H1E gene in a patient with major features of autism and intellectual disability. Our finding supports a role for linker histones in brain development and expands a spectrum of genes encoding epigenetic machinery in autism etiology. This underscores the importance of understanding the function of H1 linker histones in brain development.
| M A TE RI A L S A ND M E TH ODS
This study was approved by the Duke Institutional Review Board, and written consent for the case report and pictures was obtained from the individual's parent.
| Whole blood sample preparation
Sample was collected in K2-EDTA-coated blood collection tubes. After collection, blood was prepared as described in Lin et al. (2012) . Briefly, samples were lysed using an equal volume of lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate [Na 4 P 2 O 4 ], 1 mM b-glycerophosphate, 1 mM sodium orthovanadate (Na 3 VO 4 ), and 1 mg/mL leupeptin), vortexed for 2 min, placed on ice for 5 min, and vortexed for an additional 2 min. Samples were placed at 2808C for at least 30 min, then thawed in a 378C water bath for 3 min. Samples were vortexed 2 min and centrifuged at 14,000 3 g for 10 min at 48C. Supernatant was transferred to a new tube and immediately used.
| Quantitative immunoblot
Protein from the affected patient and an unaffected control was separated by SDS-PAGE. Proteins were transferred to PVDF membranes (Bio-Rad, Hercules, CA). Membranes were blocked with 5% nonfat milk in TRIS-buffered saline (pH 7.4, TBS) for 1 hr at room temperature.
Blots were then incubated with primary antibodies overnight at 48C. 
| Birth history
He was born at 38 weeks gestation to a G1P0 21-year-old mother via emergency C-section due to fetal distress precipitated by a maternal motor vehicle accident. His birth weight was 3.195 kg (25th percentile) and length was 49.5 cm (25th percentile). He was noted to have micrognathia and increased muscle tone at birth. He stayed in the NICU for 2 weeks due to jaundice, apnea, and poor feeding requiring orogastric feeds.
| Developmental milestones
He first sat unsupported at 9 months, and walked at 2 years. He presented with increased tone at birth but subsequently demonstrated low tone later in childhood. He began receiving developmental services, including home-based developmental therapy, then center-based speech, occupational, and physical therapy, when he was 6 months of age. At 4 years old, he had no clear spoken words but produced unintelligible, open-mouthed sounds. He is still not toilet trained at current age.
| Family history
Both maternal and paternal sides of families are Caucasian and deny any consanguinity. There is a paternal family history of developmental delay and neuropsychiatric disease, with bipolar disorder in the father, a great uncle with developmental delay, and a first cousin with paranoid schizophrenia. There is a diagnosis of depression in the mother and maternal grandmother.
3.5 | Neurobehavioral characterization 3.5.1 | Expressive language
The patient communicates through some single words (vocabulary size <10 words) and some sign language, with his overall expressive language level approximating that of an 18 month child (Table 1) .
| Receptive language
At 7 years of age he was administered the Peabody Picture Vocabulary
Test-Fourth Edition. His performance reached a standard score of <45 (raw score of 2 with a mean score of 100, and standard deviation of 15) which falls in the Extremely Low range.
| Visual motor integration
Beery-Buktenica developmental test of visual-motor integration (Beery VMI) was administered at 7 years of age to assess the individual's ability to integrate his visual and motor abilities. He attained a standard score of <45 (Raw score <2) with a mean score of 100, and standard deviation of 15.
| Adaptive development
The Vineland Adaptive Behavior Scales, Second Edition-Survey Interview was administered at 7 years of age to assess the patient's Adaptive 
| Intellectual disability
He has moderate intellectual disability determined through the clinical assessment given at age 10 years.
| Autism diagnostic evaluation
The patient received the diagnosis of autism at age four using criteria set forth by the diagnostic and statistical manual of mental disorders-iv (DSM-IV). The Autism Diagnostic Interview-Revised (ADI-R) was administered at the age of 10 years, with his score reaching a diagnosis of Autism.
| Communication skills
The patient expresses hunger by getting items of food himself (his mother stresses about his independence with such tasks). He does follow one step commands, intermittently follows two step commands, and does not follow three step commands. His speech intelligibility is less than 25%. He can wave "goodbye," blow a kiss, nod "yes" and shake his head "no," and he is able to point. His vocabulary size is 5 to 10 words, including "ook" for look, "whoa," "don't," and "bye." He jargons frequently. He signs "sorry," "thank you," and "more." The normal amino acid sequence for HIST1H1E (top) has a C-terminus (black) largely composed of K, A, and P (underlined) residues. The predicted mutated amino acid sequence (bottom) is predicted to change at the insertion point (bold), drastically reducing the content of K, A, and P residues (underlined) found in the C-terminus (red 
| Restricted and repetitive behaviors or interests
The patient displays restricted interests and possesses highly obsessive behaviors. He has a fixated interest in playing with water and others' hair, and is preferentially interested in watching YouTube videos. He likes to line up cars in a particular order.
| Other comorbidities
At 6 months of age, he underwent outpatient surgery for correction of hydrocele and hernia.
At 2 years old, a brain magnetic resonance imaging (MRI) revealed an arachnoid cyst and mild hydrocephalus, while a metabolic bone survey showed mild scoliosis. Both gross and fine motor skills are delayed.
He is able to use a spoon and fork, and requires help when brushing his teeth. He can zip up a zipper but is unable to button large or small buttons. He is able to pedal, and can ascend and descend stairs using alternating feet while holding on to a railing. Hearing evaluations have been normal. He has unusual fears (noted to fear biscuits).
At 7 years of age, the patient experienced a single grand mal seizure. However, all EEGs have been normal and he is not currently on seizure medication. Sleep disturbances are particularly challenging, as he frequently wakes up during the night.
| Genetic evaluation and basic genetic and metabolic testing
The patient was initially evaluated at the Medical Genetics Clinic at Duke Children's Hospital at 5 years of age. He received basic genetic and biochemical evaluations including tests for FMR1 triplet repeat expansion, single nucleotide polymorphism (SNP) chromosomal microarray, plasma amino acids, an acylcarnitine profile, urine and plasma creatine/guanidinoacetate, and urine organic acid analysis, SHANK3
gene sequencing (Athena Diagnostics), plasma lactate, and a biochemical screen for congenital disorder of glycosylation (Emory University Medical Genetics Laboratory). The results from these tests were unremarkable.
| Whole exome sequencing
Trio WES was performed as previously described (Tanaka et al., 2015) .
The sequencing depth and coverage are shown in Figure 1c . To better understand the impact of the c.435dupC mutation on HIST1H1E protein, we performed quantitative immunoblot staining using protein isolated from whole blood lymphocytes. As shown in Figure 1g ,h, the patient has 50% reduction of HIST1H1E protein compared to a similarly aged control. Because the epitope of the antibody against HIST1H1E targets the N-terminus (Figure 1d ), reduced HIST1H1E protein expression suggests the mutation results in haploinsufficiency due to either mutation-induced RNA decay, or an unstable truncated protein.
| Catalog of mutations in genes encoding epigenetic regulators in autism spectrum disorder
The role of epigenetics in autism spectrum disorder (ASD) has been recognized for more than two decades. Historically, MECP2, a gene encoding the X-linked methyl-CpG-binding protein 2, is known to cause Rett syndrome, a prototype for syndromic autism in females (Amir et al., 1999) . MECP2 specifically interacts with methylated DNA to mediate the transcriptional regulation through both its interaction with methylated DNA and histone methylation (Ho et al., 2008) . Similarly, the full triplet repeat expansion mutation in FMR1, a gene responsible for fragile X syndrome and the common syndromic ASD in males, 
| D ISC USSION
The etiological role of epigenetic dysregulation in ASD has long been recognized from studies of syndromic ASD, such as Rett and fragile X syndromes (Zoghbi & Beaudet, 2016) . Only recent discoveries of muta- clinical presentation is also strengthened by the recent report of three mutations of HIST1H1E (c.430dupC, c.441dupC, in five individuals presenting with clinical features of overgrowth and intellectual disability (Tatton-Brown et al., 2017) (Figure 1d ). Interestingly, the c.430dupC and c.441dupC are recurrent mutations reported in two out of five cases. Together with the mutation of c.435dupC in our patient, these findings suggest the 3 0 end of the HIST1H1E gene as a mutation "hot spot". The C-terminus of linker histones typically has a net positive charge (Subirana, 1990 ) necessary for high-affinity binding to chromatin in vivo (Hendzel et al., 2004) . The reduced HIST1H1E
protein will likely affect the chromatin structure and function.
The clinical features including overgrowth and intellectual disability reported in five cases with HIST1H1E mutations in literature are variable, even in cases with the same or similar mutations. It was also noted that the documentation of clinical features in some of these cases in the report is probably not complete (Tatton-Brown et al., 2017) . For example, the feature of large head sizes at different ages is described in three out of five cases. However, the increase in height and weight is much less consistent among cases, and varies at different ages. The birth weight in four cases is within the normal range, but higher in one case. Abnormally tall height and high weight was only reported during infancy in one case, but these measures normalized during the patient's teenage years. Similarly, intellectual disability varies from mild to severe in two cases with the same mutation of c.430dupC. A diagnosis of autism or autistic-like behaviors is not mentioned in any of these five cases. It is possible that autism or autistic behaviors are present in these cases but have not been fully assessed.
In our case with the c.435dupC mutation, we note some overlapping clinical features with the cases in literature. These include similar dysmorphic facial features such as high hairline, full checks, and micrognathia. Additionally, we report a relative high weight at age 10 year, but normal height. Our patient has a history of mild ventriculomegaly in infancy, but his current Head Circumference is in the 50th percentile.
His feature of newborn hypertonia progressing to hypotonia is similar to the case reported to have a c.436-458del23 mutation in literature While the genetic evidence strongly supports causality in autism,
little is known about how deficiency in HIST1H1E, a basic component of epigenetic machinery, causes brain dysfunction manifesting primarily as autism and intellectual disability. Triple knockout of H1 linker histone H1c, H1d, and H1e (H1TKO), including HIST1H1E, result in early embryonic lethality and 50% reduction of total H1 histones in mice (Fan et al., 2003) . Analysis in H1TKO embryonic stem cells (ESCs) revealed altered expression of select genes via modulation of DNA and histone methylation. The study of neural differentiation in H1TKO
ESCs revealed selective impairments in specification and maturation of glutamatergic and dopaminergic neurons, and their association with deregulation of expression in forebrain-derived neural stem cells (Alami et al., 2003) . Mutant mice lacking Hist1h1e only are viable, and do not have apparent developmental defects (Fan, Sirotkin, Russell, Ayala, & Skoultchi, 2001; Fan et al., 2003) . Unfortunately, behavioral and other studies of brain function in Hist1h1e mutant mice have not been
reported. An interesting hypothesis in Hist1h1e mutant mice would be to test whether haploinsufficiency of the gene selectively reduces H1
linker histone in certain neuronal cell lineages, and alters subsequent expression of genes important for brain development and function.
In summary, we report the first case of a HIST1H1E mutation associated with autism, expanding the spectrum of epigenetic-related genes in the etiology of autism. This study underscores the importance of future studies to evaluate autism in other patients carrying HIST1H1E
mutations and to understand the role of H1 linker histones in brain development and function.
